SYMBIOTEC PHARMALAB LIMITED
BSE: SYMBIOTEC544889ISIN INE899I01028
- Healthcare
- Pharmaceuticals
- BSE IPO
Share price
₹1,042.50-38.40 (-3.55%)
as of 16 Sep 2026
- 52W high
- ₹1,193.90
- 52W low
- ₹933.80
- Off 52W high
- -12.68%
- 1M return
- —
- 3M return
- —
- 6M return
- —
- 1Y return
- —
- 20D avg volume
- —
- 50 DMA
- —
- 200 DMA
- —
Key ratios
- Market cap
- ₹6,699 Cr
- Current price
- ₹1,042.50
- 52W high / low
- ₹1,193.90 / ₹933.80
- Face value
- ₹2.00
- P/E
- —
- P/B
- —
- EPS (TTM)
- —
- Book value / share
- —
- ROE
- —
- ROCE
- —
- Operating margin
- —
- Net margin
- —
- Debt / equity
- —
- Net debt
- —
- Interest cover
- —
- Dividend yield
- —
- Dividend / share (TTM)
- —
- Payout
- —
- Cash conversion cycle
- —
Filings & corporate actions
Recent announcements
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 11, 2026 for Anil Satwani, Sushil ....
- Symbiotec Pharmalab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to consider and approve To consider and approve ....
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Beacon Trusteeship Ltd
- Update on Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
- Closure of trading window for the quarter ended June 30, 2026.
- Intimation under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
- Disclosure regarding authority to determine materiality of event or information.
- Trading Members of the Exchange are hereby informed that effective from September 01, 2026, the Equity Shares of Symbiotec Pharmalab Ltd (Scrip Code: 544889) are listed and admitted to ....
Board meetings
- Board Meeting - Financial Results